Status | Study |
Completed |
Study Name: The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia Condition: Nocturia Date: 2012-02-13 Interventions: Behavioral: SyBeMeP (Systemized Behavioural Modification education Program) |
Completed |
Study Name: Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study Condition: Nocturia Date: 2011-09-14 Interventions: Drug: Desmopressin Administration of minirin melt 60 µg: desmopressin (acetate) 60 µg oral lyo |
Completed |
Study Name: Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study Condition: Nocturnal Polyuria Date: 2011-09-13 Interventions: Drug: Desmopressin 120 µg, oral lyophilisate, sublingual use |
Completed |
Study Name: Necessity for Repetitive Education of Behavioral Modification Condition: Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia) Date: 2011-01-17 Interventions: Other: education for behavioral modification a systematized 30-minutes education program for behavioral |
Completed |
Study Name: Copeptin in Differentiation of Polyuria and Polydipsia Condition: Polyuria Polydipsia Date: 2010-01-25 |
Completed |
Study Name: Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation Condition: Enuresis Polyuria Date: 2009-12-17 Interventions: Drug: desmopressin tablet Admi |
Completed |
Study Name: Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS) Condition: Nocturia Associated With Nocturnal Polyuria Date: 2009-05-14 Interventions: Drug: desmopressin desmopressin (Nocturin®) 0.1 mg tablet per day for 12 weeks |
Completed |
Study Name: Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity Condition: Nocturia Date: 2009-05-14 Interventions: Drug: Desmopressin Desmopressin 0.1,0.2 or 0.4 mg once daily for 3-weeks of dose titration phase and 4-w |
Terminated |
Study Name: Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease Condition: Parkinson Disease Date: 2008-12-09 Interventions: Drug: Desmotabs Desmotabs encapsulated, 0,2 mg once daily for one week, 0,2 mg bid for one week |
Completed |
Study Name: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus Condition: Nephrogenic Diabetes Insipidus Date: 2007-05-23 Interventions: Drug: sildenafil 25 mg quaque |